| Bid Price | High Price | ||
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 26, 2017 | 5,078.00 | 5,206.62 | 5,078.25 | 5,113.00 | 2,211,986 |
| Jul 25, 2017 | 5,107.00 | 5,164.04 | 5,077.00 | 5,087.00 | 1,337,928 |
| Jul 24, 2017 | 5,147.00 | 5,154.64 | 5,056.66 | 5,089.00 | 3,063,730 |
| Jul 21, 2017 | 5,135.00 | 5,236.67 | 5,120.50 | 5,152.00 | 1,928,163 |
| Jul 20, 2017 | 5,063.00 | 5,130.00 | 5,066.00 | 5,123.00 | 1,255,749 |
| Company Name | AstraZeneca | Epic | AZN |
|---|---|---|---|
| ISIN | GB0009895292 | Index | FTSE 100 |
| EMS | 500 | Prev Close | 5,113.00 |
| Shares in Issue (m) | 1,265.78 | Market Cap (£m) | 64,389.98 |
| PE Ratio | 18.37 | Div per Share (p) | 218.90 |
| Div Yield | 4.30 | Div Cover | 1.27 |
| EPS | 277.00 | EPS Growth (%) | 24.22 |
| PEG | 0.76 | DPS Growth (%) | 16.13 |
| ROCE | 7.51 | Net Gearing | 65.32 |
| Quick Ratio | 0.72 | Current Ratio | 0.87 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 26 Jul | Barclays Capital | Overweight | 5,113.00 | 6,300.00 | 6,300.00 | Reiterates |
| 21 Jul | Exane BNP Paribas | Neutral | 5,113.00 | - | 4.57 | Reiterates |
| 18 Jul | Goldman Sachs | Sell | 5,113.00 | 3,900.00 | 3,900.00 | Reiterates |
| 17 Jul | Liberum Capital | Buy | 5,113.00 | 5,500.00 | 5,500.00 | Reiterates |
| 13 Jul | JP Morgan Cazenove | Neutral | 5,113.00 | - | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 16 May 2017 | Pascal Soriot | Transfer Out | 163,000 @ 0.00p | £0.00 |
| 16 Dec 2016 | Pascal Soriot | Transfer Out | 59,951 @ 0.00p | £0.00 |
| 01 Nov 2016 | Graham Chipchase | Buy | 100 @ 4,807.95p | £4,807.95 |
| 01 Aug 2016 | Marc Dunoyer | Transfer In | 43,730 @ 0.00p | £0.00 |
| 14 Jun 2016 | Pascal Soriot | Transfer In | 84,316 @ 0.00p | £0.00 |
